Assessments showed a 66% reduction in pain during the session and a 33% reduction in pain at the end of the session.
Younger adults who use methamphetamine are at a greater risk for stroke.
As a response to the opioid epidemic, clinicians may be overprescribing gabapentinoids.
Even though there are concerns about opioid addiction and misuse, there are still more than 1/3 of Americans using them.
Quality of life and improved pain and function may be achieved by reducing opioid doses.
Hospitalists must use opioids judiciously, including adhering to specific dose limits and setting expectations for pain control, medication stop dates, and refills.
Patients with chronic pain may have a lower risk of becoming addicted to opioids if they are taught coping skills.
Patients receiving buprenorphine maintenance therapy for their opioid use disorder may have impaired sleep, although they report improvements in both quality and duration of sleep.
Early onset of motor symptoms related to substance abuse appeared to significantly affect women compared with men.
Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.
New research suggests that opioid addiction may be linked to a genetic variant, and more personalized treatment may help those with the change.
Results indicate that patients with AUD show significant impairments in social problem resolution task.
Patients who underwent thoracic surgery were at the greatest risk of long-term opioid use.
The 6-month implant is more expensive than the pills, costing about $4,900 -- or more than $800 a month.
Revised labeling will occur across all types of opioids.
The new guidelines come in the wake of an opioid overdose epidemic in the U.S.
Opioid prescriptions for patients with neuropathic pain may not improve their physical function or disability.
Investigators honed in on a specific lipid transmitter, the endogenous cannabinoid 2-arachidonoylglycerol (2-AG), and found that inhibition of its enzymatic biosynthesis by diacylglycerol lipase (DAGL) restores the gamma aminobutyric acid (GABA) functionality compromised by chronic nicotine exposure.
More than 90% of patients with chronic pain continue to receive prescription opioids even after an overdose.
The drug can reverse the effects of opioid overdose in as little as 2 minutes.
Over 40 health care provider groups have committed to opioid prescriber training over the next 2 years.
The CDC found that only a small number of doctors are responsible for large amounts of opioid prescriptions.
The prevalence of prescription opioid use disorder grew from 2003 to 2013.
Girls with a history of a psychiatric condition, substance abuse, or ADHD were more likely to report concussion-like symptoms.
The guidelines recommend that first responders be trained to use the opioid blocker naloxone.
Depression, substance abuse, and suicidal ideation are commonly reported in patients who have chronic pain.
Chronic drinking only causes further deterioration, U.S. physicians warn.
It's not clear why a reduction in grey matter volume was only observed in women.
People with a history of smoking or abusing drugs are at the highest risk of using opioids for the long-term.
Physicians, as well as patients, are unaware and misinformed of the dangers that come with opioid use
Neurology Advisor Articles
- Increased Mortality in Parkinson's Disease Linked to Low Antidepressant Adherence
- Age, Gender, and Cognition Predict Weight Loss in Parkinson's Disease
- MRI in Parkinson's Disease: Expanding Usability for Better Diagnostics
- Parkinson's: Sleep Disturbances Affect Clinical Motor Subtypes, Disability
- The Handoff: Your Week in Neurology News - 9/21/17
- Exenatide Presents Exciting Therapeutic Possibilities for Parkinson's Disease
- Cognitive Decline Related to Site Specific Mid-Life Adiposity
- Parkinson's, REM Sleep Disorder Combination Linked to Cognitive Decline
- Higher Doses of Pregabalin for Neuropathic Pain: Is it Safe?
- Buccal, Nasal Midazolam Most Cost-Effective for Pediatric Status Epilepticus
- Zika Virus Associated With High Risk for Neurologic Complications in Adults
- Evolocumab Has No Effect on Cognition in Patients Attaining Very Low Levels of LDL Cholesterol
- Acute Oxygen Therapy for Cluster Headahce Not Prohibitively Expensive
- β-2 Adrenergic Agonists Linked to α-synuclein Transcription and Risk of PD
- Little Evidence to Support Doctor, Patient Electronic Communication Guidelines